News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
08 18 2016 eCCF dramatically improves efficiency and time savings in workplace drug testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic services, announced today that the U.S. Department of Health and Human Services (HHS) has authorized the company to...
08 17 2016 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.40 per share,...
08 05 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 18th Annual Pacific Crest Global...
08 05 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Canaccord Genuity 36th Annual Growth...
08 04 2016 First digital testing technology from diagnostics leader is designed to help primary care physicians and ACOs improve the detection and monitoring of patients with dementias such as Alzheimer's diseaseQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced CogniSense™, a digital cognitive assessment tool that aids in a physician's...
08 03 2016 World leaders in consumer genomics and diagnostic information services team upQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and AncestryDNA, the leader in family history and consumer genomics, are teaming up to help meet the...
07 27 2016 Healthcare analytics technology from Quest Diagnostics and Inovalon supports adoption of value-based careQuest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care health analytics technology, has won two gold medals at the 2016 Golden Bridge...
07 26 2016 Study Finds Sharp Increase in Patients Who Combine Prescribed Medications with Other Drugs; Two in Three Users of Heroin Take it with Benzodiazepines, a Potentially Lethal CombinationThe majority of American adults taking opioids and other commonly prescribed medications use them in ways that put their health at risk, including potentially dangerous combinations with other...
07 21 2016 - Q2 2016 revenues of $1.91 billion, lower by 1% on a reported basis and higher by 2.4% on an equivalent basis versus 2015Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the second quarter ended June 30, 2016, reported net income...
06 30 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2016 financial results on Thursday, July...
-
06 15 2016 Largest percentage of children with very high blood lead levels concentrated in six regions, including in New York, Pennsylvania and OhioDespite four decades of public health efforts to minimize children's exposure to lead, high percentages of unsafe blood lead levels are still found in children in numerous regions of the United...
-
06 15 2016 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Safeway, one of the largest food and drug retailers in the U.S., are teaming up to offer...
-
06 14 2016 HIGHLIGHTS FROM THE QUEST DIAGNOSTICS/INOVALON STUDY INCLUDE:A new study of physicians and health plan executives suggests that the complexity of quality measures and physicians' lack of access to patient data at the point of care are barriers to the...
-
06 09 2016 Healthcare analytics technology from Quest Diagnostics and Inovalon connects with nearly 600 EHR platforms to provide actionable patient insights at the point of careQuest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care health analytics technology, has won two IT World Awards®. The solution earned...
-
06 06 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, will relocate its corporate headquarters from Madison, N.J. to Secaucus, N.J. when its...
-
06 02 2016 Biomarker monitoring may help identify athletes at risk for overtrainingFemale college athletes at their highest pre-season fitness levels may be more susceptible to overreach in a team sport environment than less fit ones, according to original research being...
-
06 02 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 2016 Global Healthcare...
-
06 01 2016 Co-Founded by Quest Diagnostics and Inserm, with LabCorp as First Member, BRCA Share is now the Largest Open BRCA Datashare of Curated BRCA Variants Clinically Suitable for Patient ManagementBRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. Mutations of...
-
05 31 2016 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the HealthONE System of HCA Healthcare (NYSE: HCA) are teaming up to enhance the quality and...
-
05 26 2016 34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual MeetingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of three new cancer test services designed to provide clinically...
-
05 23 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $500,000,000 aggregate principal amount of...
-
05 18 2016 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.40 per share,...
-
05 18 2016 - Strategy to refocus business portfolio completed with sale of Focus Diagnostics products business for $300 millionQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed efforts to refocus its business on diagnostic information...
-
05 13 2016 DiaSorin S.p.A. (FTSE Italy: DIA) today announced the completion of the transaction to acquire the Focus Diagnostics' immunodiagnostic and molecular diagnostic products business ("Focus") from...
-
04 28 2016 First Test from a Commercial Lab to Receive Emergency Use Authorization for Testing Patients in the United States, including Puerto Rico, for Zika InfectionQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use...
